logo-loader
RNS
Barclays PLC

Barclays PLC - Transaction in Own Shares

RNS Number : 1806E
Barclays PLC
23 February 2024
 

23 February 2024

Barclays PLC
Transaction in own shares

Barclays PLC (the "Company") announces that it has purchased for cancellation the following number of its ordinary shares of 25 pence each on the London Stock Exchange from J.P. Morgan Securities plc as part of its buy-back announced on 21 February 2024:

Date of purchase:

22 February 2024

Number of ordinary shares purchased:

868,117

Highest price paid per share:

160.0000p

Lowest price paid per share:

159.3000p

Volume weighted average price paid per share:

159.7949p

The Company intends to cancel all of the purchased ordinary shares.

Following the cancellation of the repurchased shares, the Company's issued share capital will consist of 15,181,954,467 ordinary shares with voting rights.

There are no ordinary shares held in Treasury.

The above figure 15,181,954,467 may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended, a full breakdown of the individual purchases of ordinary shares made by J.P. Morgan Securities plc on behalf of the Company can be found at:

http://www.rns-pdf.londonstockexchange.com/rns/1806E_1-2024-2-22.pdf

Since the commencement of the share buy-back programme announced on 21 February 2024, the Company has purchased 868,117 ordinary shares on the London Stock Exchange in aggregate at a volume weighted average price of 159.7949p per ordinary share.

- ENDS -

For further information, please contact:

Investor Relations

Marina Shchukina +44 (0) 20 7116 2526

 

 

Media Relations

Tom Hoskin +44 (0) 20 7116 4755

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGZGZZRZNGDZM
NO INVESTMENT ADVICE

This content is published by Proactive Investors Limited and made available subject to the terms and conditions of use of its website (see Terms of Use).

Proactive Investors is a full-service financial newswire. We produce independent, objective financial journalism and do not provide personalised investment advice, act as a broker, or recommend specific securities to individual investors.

Financial content published on this Site is produced under the journalist exemption provided for in Article 20 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, and in accordance with FCA guidance at PERG 8.12. Where a communication is not otherwise exempt, it is issued or approved for distribution in the UK by Proactive Investors Limited.

All information used in the preparation of this communication has been compiled from publicly available sources that we believe to be reliable, however, we cannot, and do not, guarantee the accuracy or completeness of this communication.

This communication is intended for information purposes only and does not constitute investment advice, a personal recommendation, an offer, solicitation, or inducement to buy or sell any investment or financial product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

This communication has been prepared without taking account of the objectives, financial situation or needs of any particular investor. Before entering into any transaction, investors should consider suitability for their individual circumstances and should read the relevant prospectus, term sheet, subscription agreement, information memorandum, prospectus or other offering document in full.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise, and you may not recover the amount you invest.

This communication may contain information obtained from third parties, including credit ratings and financial data. Reproduction and distribution of third-party content in any form is prohibited except with the prior written consent of the relevant third party. Credit ratings are statements of opinion and should not be relied upon as investment advice.

FOR OUR FULL DISCLAIMER CLICK HERE

Holding(s) in Company

8 hours, 20 minutes ago

Form 8.3 SPIRE HEALTHCARE GROUP PLC

9 hours, 35 minutes ago

Form 8.3 SEGRO PLC

9 hours, 54 minutes ago

Form 8.3 MOBICO GROUP PLC

10 hours, 33 minutes ago

Form 8.3 PROLOGIS, INC.

10 hours, 33 minutes ago

Form 8.3 STHREE PLC

10 hours, 34 minutes ago

Form 8.3 TATE & LYLE PLC

10 hours, 34 minutes ago

Form 8.5 EPT/Non RI EASYJET PLC

11 hours, 22 minutes ago

3 min read